B of A Securities Downgrades Cortexyme to Underperform

B of A Securities analyst Tazeen Ahmad downgrades Cortexyme (NASDAQ:CRTX) from Neutral to Underperform.

B of A Securities analyst Tazeen Ahmad downgrades Cortexyme (NASDAQ:CRTX) from Neutral to Underperform.

Total
0
Shares
Related Posts